Updated! CRA GRADE Recommendation on Covid-19 Vaccination and Feedback Survey
The Canadian Rheumatology Association (CRA) has updated their formal GRADE recommendation for Covid-19 vaccination in persons with autoimmune rheumatic disease. The recommendation now focuses on the use of the 4 currently approved COVID vaccines: BNT 162b2 (Pfizer-BioNTech); mRNA-1273 (Moderna); ChAdOx1 (AstraZeneca Oxford; Serum Institute of India); and Ad26.COV2.S (Johnson & Johnson) vaccines. Thank you to the Canadian Arthritis Patient Alliance (CAPA) for providing valuable patient input throughout the development of this recommendation.
As this is a ‘living guideline’, it will be updated on an ongoing basis as new evidence emerges. All are welcome to comment on this recommendation, including physicians, patients, caregivers, and members of the public. Please note that CRA will only follow up with individuals if additional information is required, and will not be providing any medical advice or guidance to patients. Patients should discuss their unique considerations with their rheumatologist.
Click here to provide input.